PeartWS. General review of hypertension. In: GenestJ, KuchelO, HametP, CantinM, eds. Hypertension. New York: McGraw-Hill, 1983:3–14.
2.
PageLB. Epidemiology of hypertension. In: GenestJ, KuchelO, HametP, CantinM, eds. Hypertension. New York: McGraw-Hill, 1983:683–99.
3.
RojkindML, Perez-TamayoR.Liver fibrosis. Int Rev Connective Tissue Res1983;10:333–93.
4.
ChenT SM, LeevyCM. Collagen biosynthesis in liver disease of the alcoholic. J Lab Clin Med1975;85:103–12.
5.
LieberCS. Alcohol, liver, and nutrition. J Am Coll Nutr1991;10:602–32.
6.
KamegayaK, OkazakiI, MaruyamaK, TsuchiyaM.Ethanol, acetaldehyde and lactic acid stimulate type III and IV collagen synthesis of cultured Chang liver cells-immunoelectron microscope study. Ann NY Acad Sci1991;625:832–4.
7.
HalstedCH, VillanuevaJ, ChandlerCJ, ReubnerB, MunnRJ, ParkkilaS, NiemelaO.Centrilobular distribution of acetaldehyde and collagen in ethanol-fed micropig. Hepatology1993;18:954–60.
8.
TakaseS, TakadaA, UrashimaS, EnyamaK, FujiiM.Changes in the markers related to collagen synthesis in the liver of chronically alcohol treated rats. Gastroenterologia Japonica1992;27:54–60.
9.
HattoriS, ItoshimaT, TsujiT.Proliferation of collagen fibrils and Ito cells in the liver after Japanese sake administration in undernourished rats as demonstrated by scanning electron microscopy.Gastroenterologia Japonica1992;27:43–53.
10.
LieberCS. Alcohol and fibrogenesis. Alcohol Alcohol Suppl1991;1:339–44.
11.
CasiniA, CunninghamM, RojkindM, LieberCS. Acetaldehyde increases procollagen type 1 and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology1991;13:758–65.
12.
CasiniA, GalliG, SalzanoR, CeniE, FranceschelliF, RotellaCM. Acetaldehyde induces C-FOS and C-JUN proto-oncogenes in fat-storing cell cultures through protein kinase C activation. AlcoholAlcohol1994;29:303–14.
13.
MoshageH, CasiniA, LieberCS. Acetaldehyde selectively increases collagen synthesis in cultured rat fat-storing cells but not in hepatocytes. Hepatology1990;12:511–18.
14.
LieberCS. Hepatic and metabolic effects of ethanol: pathogenesis and prevention. Ann Med1994;26:325–30.
15.
LieberCS. Biochemical factors in alcoholic liver disease. SeminLiver Dis1993;13:136–53.
16.
AragonCMG, RoganF, AmitZ.Ethanol metabolism in rat brain homogenate by a catalase-H2O2 system. Biochem Pharmacol1992;44:93–8.
17.
Fraenkel-ConratH, CooperM, OlcottHS. The reaction of formaldehyde with proteins. J Am Chem Soc1945;67:950–4.
18.
Fraenkel-ConratH, OlcottHS. The reaction of formaldehyde with proteins V. Cross-linking between amino and primary amide or guanidyl groups. J Am Chem Soc1945;70:2673–84.
19.
Fraenkel-ConratH, OlcottHS. Reaction of formaldehyde with proteins. VI. Cross-linking of amino groups with phenol, imidazole, or indole groups. J Biol Chem1948;174:827–43.
20.
RatnerS, ClarkeHT. The action of formaldehyde upon cysteine.J Am Chem Soc1937;59:200–6.
21.
Fraenkel-ConratH, BrandonBA, OlcottHS. The reaction of formaldehyde with proteins IV. Participation of indole groups.Gramicidin. J Biol Chem1947;168:99–118.
KoterbaAP, SmolenS, JosephA, BasistaMH, BrecherAS. Coagulation protein function. II. Influence of thiols upon acetaldehyde effects. Alcohol1995;12:49–57.
BrecherAS, RileyC, BasistaMH. Acetaldehyde-modified lysozyme function: its potential implication in the promotion of infection in alcoholics. Alcohol1995;12:169–72.
26.
ThevanantherS, BrecherAS. Interaction of acetaldehyde with plasma proteins of the renin-angiotensin system. Alcohol1994;11:493–9.
27.
BrecherAS, PavlockJL. Acetaldehyde decreases the antitryptic activity of α1-antitrypsin. Alcohol1992;9:181–4.
28.
BrecherAS, ThevanantherS, Franco-SaenzR.Acetaldehyde inhibits the anti-elastase activity of α1-antitrypsin. Alcohol1994;11:181–5.
29.
MaherJJ, ZiaS, TzarakisC.Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts. Alcohol Clin ExpRes1994;18:403–9.
30.
KawaharaH, MatsudaY, TsuchishimaM, WangXE, TakadaA.Effects of ethanol and acetaldehyde on the maturation of hepatic secretory glycoproteins. Alcohol Alcohol Suppl1993;1A:29–35.
31.
BrillaCG, WeberKT. Reactive and reparative fibrosis in arterial hypertension in the rat. Cardiovas Res1992;26:671–7.
32.
BrecherAS, StaufferR, KnightJ.Acetaldehyde inhibits serum aminopeptidases. Alcohol (in press).
33.
KuglerP.On Angiotensin-degrading aminopeptidases in the rat kidney. Adv Anat Embryol Cell Biol1982;76:1–86.
34.
PageIH. Some regulatory mechanisms of renovascular and essential arterial hypertension. In: GenestJ, KoiwE, KuchelO, HametP, CantinM, eds. Hypertension. New York: McGraw-Hill, 1977;576–87.
35.
KhoslaMC, SmebyRR, BumpusFM. Structure-activity relationship in angiotensin II analogs. In: PageIM, BumpusFM, eds. Angiotensin. New York: Springer-Verlag, 1974;126–61.
36.
BoucherR, Rojo-OrtegaJM, GenestJ.Description of reninangiotensin system and methods of measurement. In: GenestJ, KoiwE, KuchelO, HametP, CantinM, eds. Hypertension. New York: McGraw-Hill, 1977;140–55.
37.
DaviesDL, McElroyK, AtkinsonAB, BrownJJ, CummingAMM, FraserR, LeckieBJ, LeverAF, McKayA, MortonJJ, RobertsonJI. Relationship between exchangeable sodium and blood pressure in different forms of hypertension in man. Clin Sci1979;57(suppl):69S–75.
38.
SanoH.Effect of angiotensin II on collagen metabolism in cultured rat cardiac fibroblasts: its relation to cardiac hypertrophy.Hokkaido Igaku Zasshi1994;69:25–34.
39.
SunY, RatajskaA, ZhouG, WeberKT. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med1993;122:395–403.
40.
VillarrealFJ, KimNN, UngabGD, PrintzMP, DillmannWH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation1993;88:2849–61.
41.
WolfG, HaberstrohU, NeilsonEG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol1992;140:95–107.
42.
WolfG, KillenPD, NeilsonEG. Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regulation1991;2:219–27.
43.
KatoH, SuzukiH, TajimaS, OgataY, TominagaT, SatoA, SarotaT.Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens1991;9:17–22.
44.
BrillaCG, PickR, TanLB, JanickiJS, WeberKT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res1990;67:1355–64.
45.
TakasakiI, ChobanianAV, SarzaniR, BrecherP.Effect of hypertension on fibronectin expression in the rat. J Biol Chem1990;265:21935–9.
46.
CrawfordDC, ChobanianAV, BrecherP.Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. CircRes1994;74:727–39.
47.
SaouafR, TakasakiI, EastmanE, ChobanianAV, BrecherP.Fibronectin biosynthesis in the rat aorta in vivo. Changes due to experimental hypertension. J Clin Invest1991;88:1182–9.
48.
KoibuchiY, LeeWS, GibbonsGH, PrattRE. Role of transforming growth factor - β1 in the cellular growth response to angiotensin II.Hypertension1993;21:1046–50.
KawaguchiY, KitaniA, HaraM, HarigaiM, HiroseT, SuzukiK, KawakamiM, HidakaT, IshizukaT, KawagoeM, NakamuraH.Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: Contribution to collagen synthesis and fibrosis. J Rheumatol1992;19:1195–201.
51.
ShibanumaM, MashimoJI, MitaA, KurokiT, NoseK.Cloning from mouse osteoblastic cell line of a set of transforming-growth-factor-β1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem1993;217:13–9.
52.
MajeskyMW, LindnerV, TwardzikDR, SchwartzSM, ReidyMA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest1991;88:904–10.
53.
ten DijkeP, IwataKK, GoddardC, PielerC, CanalisE, McCarthyTL, CentrellaM.Recombinant TGF- type β3: Biological activities and receptor binding properties in isolated bone cells. Mol Biol(USA)1990;10:4473–9.
54.
DaemenMJAP, LombardiDM, BosmanFT, SchwartzSM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res1991;68:450–6.
55.
GibbonsGH, PrattRE, DzauVJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-β1expression determines growth response to angiotensin II. J Clin Invest1992;90:456–61.
56.
NaftilanAJ, PrattRE, DzauVJ. Induction of platelet-derived growth factor A chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest1989;83:1419–24.
57.
DzauVJ, GibbonsGH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol1988;62:30–5.
58.
OwensGK. Control of hypertrophic vs hyperplastic growth of vascular smooth muscle cells. Am J Physiol1989;257:H1755–65.
59.
SarzaniR, BrecherP, ChobanianAV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest1989;83:1404–8.
KagamiS, BorderWA, MillerDE, NobleNA. Angiotensin IIstimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest1994;93:2431–7.
62.
SadoshimaJ, IzumoS.Molecular characterization of angiotensinII-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res1993;73:413–23.
63.
WolfG, MuellerE, StahlRA, ZiyadehFN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest1993;92:1366–72.
64.
SambhiMP, SwaminathanN, WangH, RongH.Increased EGFbinding and EGFR mRNA expression in rat aorta with chronic administration of pressor angiotensin II. Biochem Med Metab Biol1992;48:8–18.
65.
RaineyWE, NavilleD, MasonJJ. Regulation of 3-beta-hydroxysteroid dehydrogenase in adrenal cortical cells: effects of angiotensin-IIand transforming growth factor-beta. Endoc Res1991;17:281–96.
66.
KeramidasM, ChambazEM, FeigeJJ. Inhibition of adrenocortical steroidogenesis by alpha-2-macroglobulin is caused by associated transforming growth factor-beta. Mol Cell Endocrinol1992;84:243–51.
67.
GuptaP, Franco-SaenzR, MulrowPJ. Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerubosa cells. Endocrinology1993;132:1184–8.
68.
OlsenNJ, ZhouP, OngH, KovacsWJ. Testosterone induces expression of transforming growth factor-beta1 in the murine thymus. JSteroid Biochem Mol Biol1993;45:327–32.
69.
MassaguéJ.The transforming growth factor-β family. Annu RevCell Biol1990;6:597–641.
70.
BienkowskiRS, GotkinMG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med1995;209:118–40.
71.
GessinJC, BrownLJ, GordonJS, BergRA. Regulation of collagen synthesis in human dermal fibroblasts in contracted collagen gels by ascorbic acid, growth factors, and inhibitors of lipid peroxidation. ExpCell Res1993;206:283–90.
72.
OkudaS, LanguinoLR, RuoslahtiE, BorderWA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest1990;86:453–62.
73.
IsakaY, FujiwaraY, UedaN, KanedaY, KamadaT, ImaiE.Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest1993;92:2597–601.
BorderWA, OkudaS, LanguinoLR, RuoslahtiE.Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int1990;37:689–95.
76.
BorderWA, RuoslahtiE.Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest1992;90:1–7.
77.
WolfG, SharmaK, ChenY, EricksenM, ZiyadehFN. High glucose-induced proliferation in mesangial cells is reversed by autocrineTGF-B. Kidney Int1992;42:647–56.
78.
KanameS, UchidaS, OgataE, KurokawaK.Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. KidneyInt1992;42:1319–27.
79.
NakamuraT, OkudaS, RuoslahtiE, BorderWA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int1992;41:1213–21.
80.
ZiyadehF, SharmaK, EricksenM, WolfG.Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β.J Clin Invest1994;93:536–42.
81.
RoccoMV, ZiyadehFN. Transforming growth factor-beta: an update on systemic and renal actions. In: GoldfarbS, ZiyadehFN, eds.Hormones, autacoids, and the kidney. New York: Churchill Livingstone,1991;391–410.
82.
RobertsAB, McCuneBK, SpornMB. TGF-B: regulation of extracellular matrix. Kidney Int1992;41:557–9.
83.
RizzinoA.Transforming growth factor-β: multiple efects on cell differentiation and extracellular matrix. Dev Biol1988;130:411–22.
84.
IgnotzRT, EndoT, MassagueJ.Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J BiolChem1987;261:6443–6.
85.
KaganHM. Characterization and regulation of lysyl oxidase. In:MechanRP, ed. Biology of Extracellular Matrix. New York: AcademicPress, 1986;1:321–98.
86.
KuivaniemiH, KorhonenRM, VaheriA, KivirikkoKI. Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. FEBS Lett1986;195:261–4.
87.
WessTJ, WessL, MillerA.The in vitro binding of acetaldehyde to collagen studied by neutron activation. Alcohol Alcohol1994;29:403–9.
BoyerTD. Cirrhosis of the liver. In: WyngaardenJB, SmithLH, eds. Cecil textbook of medicine. Philadelphia: Saunders, 1985;835–45.
90.
SharmaK, ZiyadehFN. The emerging role of transforming growth factor-beta in kidney diseases. Am J Physiol1994;266:F829–42.
91.
PardoMindan FJ, PanizoA.Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J1993;14(suppl J):12–4.
92.
BrillaCG, ReamsGP, MaischB, WeberKT. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J1993;14(suppl J):57–61.
93.
SchwartzkopffB, MotzW, VogtM, StrauerBE. Heart failure on the basis of hypertension. Circulation1993;87 (suppl 5):IV 66–72.
94.
RobertV, BesseS, VanThiemN, SwynghedauwB, DelcayreC.Restructuring of the collagen network in hypertension: role of the angiotensin-aldosterone system. Arch Mal Coeur Vaiss1993;86:1113–7.
SchwartzkopffB, FrenzelH, DieckerhoffJ, BetzP, FlasshoveM, SchulteMD, MundheukeM, MotzW, StrauerBE. Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J1992;13(suppl D):12–23.
97.
WeberKT, BrillaCG. Pathological hypertrophy and cardiac interstitutium. Fibrosis and renin-angiotensin-aldosterone system.Circulation1991;83:1849–65.
98.
EdwardsDR, MurphyG, ReynoldsJJ, WhithamSE, DochertyAJP, AngelP, HeathJK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitors. EMBO J1987;6:1899–904.
99.
KerrLD, MillerDB, MatrisianL.TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell1990;61:267–78.
100.
LaihoM, SakselaO, AndreasenPA, Keski-OjaJ.Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol1986;103:2403–10.
101.
WrightJK, CawstonTE, HazlemanBL. Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. BiochimBiophys Acta1991;1094:207–10.
102.
OverallCM, WranaJL, SodekJ.Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. JBiol Chem1989;264:1860–9.
103.
LundLR, RiccioA, AndreasenPA, NielsonLS, KristensenP, LaihoM, SakselaO, BlasiF, DanK.Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor in mRNA in WI-38 human lung fibroblasts.EMBO J1987;6:1281–6.
104.
SawdeyM, PodorTJ, LoskutoffDJ. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-β1, lipopolysaccharide and tumor neurosis factor-alpha. J Biol Chem1989;264:10396–401.
105.
McAnultyRJ, CampaJS, CambreyAD, LaurentGJ. The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro. Biochim Biophys Acta1991;1091:231–5.
106.
CarterEA, McCarronMJ, AlpertE, IsselbacherKJ. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.Gastroenterology1982;82:526–34.
107.
FeinmanL, FecherR, LueSL, LieberCS. Aldehyde content of collagen from alcoholic cirrhotic and noncirrhotic human livers. ExpMol Pathol1979;30:271–8.